Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 3,000 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
Alimentary Pharmacology & Therapeutics, 2023Machine learning identifies novel blood protein predictors of penetrating and stricturing complications in newly diagnosed paediatric Crohn's disease
Ungaro R., Hu L., Ji J. et al.
Olink Target 96
Nature Communications, 2023Interpreting biologically informed neural networks for enhanced proteomic biomarker discovery and pathway analysis
Hartman E., Scott A., Karlsson C. et al.
Thrombosis Research, 2023Plasma protein signatures for high on-treatment platelet reactivity to aspirin and clopidogrel in peripheral artery disease
Baidildinova G., Pallares Robles A., ten Cate V. et al.
Journal of the American Heart Association, 2023Causal Effects of YKL‐40 on Ischemic Stroke and Its Subtypes: A 2‐Sample Mendelian Randomization Study
Xu Q., Sun L., Wang Y. et al.
Cell Reports Medicine, 2023Plasma proteins and onset of type 2 diabetes and diabetic complications: Proteome-wide Mendelian randomization and colocalization analyses
Yuan S., Xu F., Li X. et al.
Olink Explore 3072/384
Vascular Pharmacology, 2023Circulating soluble IL-6 receptor associates with plaque inflammation but not with atherosclerosis severity and cardiovascular risk
Edsfeldt A., Gonçalves I., Vigren I. et al.
Science Translational Medicine, 2023A complement atlas identifies interleukin-6–dependent alternative pathway dysregulation as a key druggable feature of COVID-19
Van Damme K., Hoste L., Declercq J. et al.
Arthritis & Rheumatology, 2023Elevation of IL‐17 Cytokines Distinguishes Kawasaki Disease From Other Pediatric Inflammatory Disorders
Brodeur K., Liu M., Ibanez D. et al.
Olink Target 48
Journal for ImmunoTherapy of Cancer, 2023Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancer
Anker J., Pal S., Kim-Schulze S. et al.
Liver International, 2023Binge drinking episode causes acute, specific alterations in systemic and hepatic inflammation‐related markers
Stankevic E., Israelsen M., Juel H. et al.
Journal of Endocrinological Investigation, 2023Serum biomarkers related to frailty predict negative outcomes in older adults with hip fracture
Cedeno-Veloz B., Lozano-Vicario L., Rodríguez-García A. et al.
Nature Communications, 2023Genetic analysis of blood molecular phenotypes reveals common properties in the regulatory networks affecting complex traits
Brown A., Fernandez-Tajes J., Hong M. et al.
Journal of Cancer Research and Clinical Oncology, 2023Genetically determined circulating resistin concentrations and risk of colorectal cancer: a two-sample Mendelian randomization study
Pham T., Nimptsch K., Papadimitriou N. et al.
Aging Cell, 2023Peripheral inflammatory biomarkers are associated with cognitive function and dementia: Framingham Heart Study Offspring cohort
Chen J., Doyle M., Fang Y. et al.
Antioxidants, 2023Genetics of Plasma Bilirubin and Associations between Bilirubin and Cardiometabolic Risk Profiles in Danish Children and Adolescents
Ullah A., Stankevic E., Holm L. et al.
Journal of Cerebral Blood Flow & Metabolism, 2023A cluster of blood-based protein biomarkers associated with decreased cerebral blood flow relates to future cardiovascular events in patients with cardiovascular disease
Overmars L., Kuipers S., van Es B. et al.
iScience, 2023Transcriptomic and proteomic assessment of tocilizumab response in a randomized controlled trial of patients hospitalized with COVID-19
Shivram H., Hackney J., Rosenberger C. et al.
Nature Immunology, 2023Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets
Zhao J., Stacey D., Eriksson N. et al.
eClinicalMedicine, 2023Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory mantle cell lymphoma (CITADEL-205): a phase 2 study
Zinzani P., Trněný M., Ribrag V. et al.
Nature Genetics, 2023Converging evidence from exome sequencing and common variants implicates target genes for osteoporosis
Zhou S., Sosina O., Bovijn J. et al.
3247 publications
Items per page
1801-1820 of 3247 publications